Intelligence · Clinical Pipeline
Oncology · Phase I
Oncology programs at Phase I — ClinicalTrials.gov pipeline intelligence.
- Programs
- 1,344
Quick answer
Oncology Phase I programs: NovaPharmaNews indexes 1,344 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Chinese Academy of 70 programs
- First People's Hospital 62 programs
- Takeda 49 programs
- United Therapeutics Europe 41 programs
- BEONE MEDICINES AUS 40 programs
- Anaxis Pharma 35 programs
- Regeneron UK 34 programs
- Janssen-Cilag International N.V 30 programs
- Novartis India 29 programs
- Chongqing Precision Biotech 27 programs
- Boehringer Ingelheim 26 programs
- BRIGHT MINDS BIOSCIENCES 23 programs
-
entinostat
Syndax Pharmaceuticals
Lung Cancer
1 trial -
etrumadenant
Arcus Biosciences
GastroEsophageal Cancer
1 trial -
evorpacept
ALX ONCOLOGY HOLDINGS INC
Acute Myeloid Leukemia
1 trial -
forodesine hydrochloride
Biocryst
Cancer
1 trial -
hCD19.IL15.CAR-iNKT
The First People's Hospital of Lianyungang
Acute Lymphoblastic Leukemia
1 trial -
haploid allogeneic NK cell therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia
1 trial -
human HER2-targeted CAR-M cells
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
hypo-fractionated SRS
United Therapeutics Europe Ltd
Metastatic Cancer
1 trial -
iC9.GD2.CAR.IL-15 T Infusion
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
idronoxil
KAZIA THERAPEUTICS LTD
Unspecified Adult Solid Tumor, Protocol Specific
1 trial -
illuccix 68Ga-PSMA-11 Total Body PET-CT
Telix Innovations
Metastatic Castration-resistant Prostate Cancer
1 trial -
imatinib mesylate
Children's Hospital of Fudan University
Leukemia
1 trial -
indibulin
Alaunos Therapeutics
Advanced Cancer
1 trial -
indibulin
Alaunos Therapeutics
Solid Tumors
2 trials -
interleukin-4 PE38KDEL cytotoxin
NEUROCRINE BIOSCIENCES INC
Breast Cancer
1 trial -
limonene containing massage oil
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
liposomal cytarabine
Pacira Ireland Limited
Brain and Central Nervous System Tumors
1 trial -
mitoxantrone hydrochloride
Karyopharm Therapeutics Inc
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
1 trial -
neratinib
PUMA BIOTECHNOLOGY, INC.
Tumors
1 trial -
nesvacumab (REGN910/ SAR307746)
Regeneron UK Limited
Solid Tumors
2 trials -
olaparib
United Therapeutics Europe Ltd
Advanced Cancer
1 trial -
ombrabulin (AVE8062)
Sanofi Pasteur
Neoplasms, Malignant
1 trial -
oncolytic virus (OVV-01) injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Neoplasms
1 trial -
oral palifosfamide tris
Alaunos Therapeutics
Advanced Cancer
1 trial -
pCAR-19B cells
Chongqing Precision Biotech Co., Ltd
Acute Lymphoblastic Leukemia, in Relapse
1 trial -
pTVG-HP with rhGM-CSF
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
palifosfamide-tris
Alaunos Therapeutics
Advanced Solid Tumors
1 trial -
pd-1 and DC-NK cells
The First People's Hospital of Lianyungang
Solid Tumor
1 trial -
pd-1 and dc-cik cells
The First People's Hospital of Lianyungang
Solid Tumor
1 trial -
prophylactic 4SCAR19 cells
The First People's Hospital of Lianyungang
B Acute Lymphoblastic Leukemia
1 trial -
rSIFN-co
Sichuan Provincial People's Hospital
Carcinoma, Non-Small-Cell Lung
1 trial -
selinexor
Karyopharm Therapeutics Inc
B-cell Lymphoma
1 trial -
selinexor
Karyopharm Therapeutics Inc
Recurrent Melanoma
1 trial -
sphingosine kinase-2 inhibitor ABC294640
Apogee Therapeutics
Pancreatic Cancer
1 trial -
standard chemotherapy medicine combined with Chinese herbs
The First People's Hospital of Lianyungang
Carcinoma, Non-Small-Cell Lung
1 trial -
standard dose capecitabine
Karyopharm Therapeutics Inc
Rectal Neoplasms
1 trial -
uCD7 CART
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia (AML)
1 trial -
universal CLL1 CAR-T cells
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
veliparib
BRIGHT MINDS BIOSCIENCES INC.
Small Cell Lung Cancer SCLC
1 trial -
zanzalintinib
Arcus Biosciences
Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors
1 trial -
ziftomenib
Kura Oncology
Gastrointestinal Stromal Tumor (GIST)
1 trial -
zimberelimab
Arcus Biosciences
Advanced Solid Tumors
1 trial -
ziv-aflibercept
Regeneron UK Limited
Cancer
2 trials -
ziv-aflibercept
Regeneron UK Limited
Lymphoma
2 trials -
α-lactalbumin vaccine
Anixa Biosciences Inc
Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer
1 trial -
γδT Cell infusion agent
The First People's Hospital of Lianyungang
Leukemia, B-cell
1 trial -
AMG 436 as monotherapy and combination therapy in participants with Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors
Amgen
microsatellite instability high/mismatch repair deficient (MSI-H/dMMR) solid tumors
1 trial -
„INSIGHT“ An explorative, open-labeled, phase I trial to evaluate feasibility and safety of eftilagimod alpha (IMP321, a LAG-3Ig fusion protein acting as LAG-3 agonist) in combination with immunotherapeutic, targeted or chemotherapeutic agents or when administered via new routes of application in advanced stage solid tumors
The George Institute
Histologically confirmed locally advanced or metastatic solid tumor (Strata A, B, D): Specification for Stratum C: Only patients with NSCLC adenocarcinomas, (squamous or adenosquamous not permitted) who are scheduled to receive platin + pembrolizumab + pemetrexed standard treatment (only for Stratum C) Specification for Stratum E: Including only metastatic or irresectable locally advanced urothelial carcinomas (only for Stratum E)
1 trial
Frequently asked questions
How many oncology Phase I programs exist?
1,344 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs